- Home
- BGLC vs MITQ Comparison
BGLC vs MITQ Comparison
Compare BGLC & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- MITQ
- Stock Information
- Founded
- BGLC 2017
- MITQ N/A
- Country
- BGLC Malaysia
- MITQ United States
- Employees
- BGLC N/A
- MITQ N/A
- Industry
- BGLC Medical Specialities
- MITQ Telecommunications Equipment
- Sector
- BGLC Health Care
- MITQ Telecommunications
- Exchange
- BGLC Nasdaq
- MITQ Nasdaq
- Market Cap
- BGLC 5.8M
- MITQ 6.6M
- IPO Year
- BGLC N/A
- MITQ 2021
- Fundamental
- Price
- BGLC $0.38
- MITQ $0.93
- Analyst Decision
- BGLC
- MITQ
- Analyst Count
- BGLC 0
- MITQ 0
- Target Price
- BGLC N/A
- MITQ N/A
- AVG Volume (30 Days)
- BGLC 10.9M
- MITQ 4.5M
- Earning Date
- BGLC 02-20-2025
- MITQ 02-12-2025
- Dividend Yield
- BGLC N/A
- MITQ N/A
- EPS Growth
- BGLC N/A
- MITQ N/A
- EPS
- BGLC N/A
- MITQ N/A
- Revenue
- BGLC $9,259,858.00
- MITQ $18,756,000.00
- Revenue This Year
- BGLC N/A
- MITQ N/A
- Revenue Next Year
- BGLC N/A
- MITQ N/A
- P/E Ratio
- BGLC N/A
- MITQ N/A
- Revenue Growth
- BGLC N/A
- MITQ N/A
- 52 Week Low
- BGLC $0.21
- MITQ $0.42
- 52 Week High
- BGLC $3.39
- MITQ $1.55
- Technical
- Relative Strength Index (RSI)
- BGLC 59.27
- MITQ 69.55
- Support Level
- BGLC $0.33
- MITQ $0.68
- Resistance Level
- BGLC $0.41
- MITQ $1.55
- Average True Range (ATR)
- BGLC 0.11
- MITQ 0.15
- MACD
- BGLC 0.01
- MITQ 0.02
- Stochastic Oscillator
- BGLC 23.68
- MITQ 33.83
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.